Maintenance of Heartburn Relief After Step-Down From Twice-Daily Proton Pump Inhibitor to Once-Daily Dexlansoprazole Modified Release

Clinical Gastroenterology and Hepatology

Volumn 10, Issue 3, 2012, Pages 247-253

  Fass, Ronnie ^a   Inadomi, John ^b   Han, Cong ^c   Mody, Reema ^c   O'Neil, Janet ^c   Perez, M Claudia ^c  

^a SOUTHERN ARIZONA VA HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c TAKEDA PHARMACEUTICALS   (United States)

Author keywords

Acid; Dose; Erosive Esophagitis; TAK 390 MR

Indexed keywords

ACETYLSALICYLIC ACID; ESOMEPRAZOLE; LANSOPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PLACEBO; PROTON PUMP INHIBITOR; RABEPRAZOLE;

ADULT; ARTICLE; BITE; BREAST CANCER; CELLULITIS; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DEPRESSION; DIARRHEA; DISEASE CONTROL; DISEASE SEVERITY; DIVERTICULITIS; DIZZINESS; DRUG EFFICACY; DRUG ERUPTION; DRUG INDUCED HEADACHE; DRUG INTOXICATION; DRUG RELEASE; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSPNEA; FEMALE; GASTRITIS; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMAN; INSOMNIA; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PATIENT ASSESSMENT OF UPPER GASTROINTESTINAL DISORDER SYMPTOM SEVERITY INDEX; PATIENT COMPLIANCE; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCREENING TEST; SINGLE BLIND PROCEDURE; SUICIDAL BEHAVIOR; SYMPTOM; TREATMENT DURATION; TREATMENT OUTCOME; UPPER RESPIRATORY TRACT INFECTION;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMANS; MALE; MIDDLE AGED; PROTON PUMP INHIBITORS; QUALITY OF LIFE; SINGLE-BLIND METHOD; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84857195670     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2011.11.021     Document Type: Article

References (12)

1. Fass R. Proton pump inhibitor failure-what are the therapeutic options?. Am J Gastroenterol 2009, 104(Suppl 2):S33-S38.
2. Kahrilas P.J., Shaheen N.J., Vaezi M.F., et al. American Gastroenterological Association medical position statement on the management of gastroesophageal reflux disease. Gastroenterology 2008, 135:1383-1391.
3. Chey W.D., Mody R.R., Wu E.Q., et al. Treatment patterns and symptom control in patients with GERD: US community-based survey. Curr Med Res Opin 2009, 25:1869-1878.
4. Heidelbaugh J.J., Goldberg K.L., Inadomi J.M. Overutilization of proton pump inhibitors: a review of cost-effectiveness and risk [corrected]. Am J Gastroenterol 2009, 104(Suppl 2):S27-S32.
5. de la Loge C., Trudeau E., Marquis P., et al. Cross-cultural development and validation of a patient self-administered questionnaire to assess quality of life in upper gastrointestinal disorders: the PAGI-QOL. Qual Life Res 2004, 13:1751-1762.
6. Rentz A.M., Kahrilas P., Stanghellini V., et al. Development and psychometric evaluation of the patient assessment of upper gastrointestinal symptom severity index (PAGI-SYM) in patients with upper gastrointestinal disorders. Qual Life Res 2004, 13:1737-1749.
7. Vakily M., Zhang W., Wu J., et al. Pharmacokinetics and pharmacodynamics of a known active PPI with a novel dual delayed release technology, dexlansoprazole MR: a combined analysis of randomized controlled clinical trials. Curr Med Res Opin 2009, 25:627-638.
8. Peduzzi P., Concato J., Feinstein A.R., et al. Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates. J Clin Epidemiol 1995, 48:1503-1510.
9. Fass R., Shapiro M., Dekel R., et al. Systematic review: proton-pump inhibitor failure in gastro-oesophageal reflux disease-where next?. Aliment Pharmacol Ther 2005, 22:79-94.
10. Fass R., Tougas G. Functional heartburn: the stimulus, the pain, and the brain. Gut 2002, 51:885-892.
11. Inadomi J.M., McIntyre L., Bernard L., et al. Step-down from multiple- to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs. Am J Gastroenterol 2003, 98:1940-1944.
12. Cote G.A., Ferreira M.R., Rozenberg-Ben-Dror K., et al. Programme of stepping down from twice daily proton pump inhibitor therapy for symptomatic gastro-oesophageal reflux disease associated with a formulary change at a VA Medical Center. Aliment Pharmacol Ther 2007, 25:709-714.